Catalent Inc Stock Ownership - Who owns Catalent?

Insider buying vs selling

Have Catalent Inc insiders been buying or selling?
Christa KreuzburgDirector2024-01-25523$50.41
Alessandro MaselliPresident CEO2023-12-081,924$37.18
Aristippos GennadiosGroup Pres. Pharma Consumer2023-12-08367$37.18
Ricky HopsonPres. Clinical Dev Supply Div2023-12-08256$37.18
Scott GuntherSVP Quality Reg. Affairs2023-12-08250$37.18
Christa KreuzburgDirector2023-10-271,245$39.32
Patricia HuntPres. Consumer Health Div2023-10-1622$46.52
Michelle R. RyanDirector2023-08-311,000$49.98
John J. GreischExecutive Chair2023-08-3021,000$50.24
Michael J. GrippoSVP Strategy Corp. Dev.2023-08-24390$44.50

1 of 5

CTLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTLT insiders and whales buy or sell their stock.

CTLT Shareholders

What type of owners hold Catalent Inc stock?
Blackstone Healthcare Partners LLC22.15%40,030,960$2.34BInsider
Vanguard Group Inc11.17%20,186,499$1.18BInstitution
Capital World Investors10.56%19,079,994$1.11BInstitution
Blackrock Inc8.95%16,176,100$944.68MInstitution
Janus Henderson Group PLC7.33%13,249,339$773.76MInstitution
Nomura Holdings Inc6.36%11,487,342$670.86MInstitution
T Rowe Price Investment Management Inc6.20%11,209,374$654.63MInstitution
Peter Zippelius4.80%8,672,903$506.50MInsider
Price T Rowe Associates Inc4.66%8,427,340$492.16MInstitution
State Street Corp4.13%7,456,058$435.43MInstitution

1 of 3

CTLT vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTLT79.66%20.34%Net BuyingNet Selling
ELAN90.61%9.39%Net SellingNet Selling
NBIX69.67%30.33%Net SellingNet Selling
TEVA51.70%0.93%Net SellingNet Selling

Catalent Stock Ownership FAQ

Who owns Catalent?

Catalent (NYSE: CTLT) is owned by 109.42% institutional shareholders, 27.94% Catalent insiders, and 0.00% retail investors. Blackstone Healthcare Partners LLC is the largest individual Catalent shareholder, owning 40.03M shares representing 22.15% of the company. Blackstone Healthcare Partners LLC's Catalent shares are currently valued at $2.35B.

If you're new to stock investing, here's how to buy Catalent stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.